Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)

Clinical trial NCT06114004 · RECRUITING

Trial details

NCT number: NCT06114004
Sponsor: Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma,Soft Tissue

Start date: 2023-09-28
Primary completion: 2026-05-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.